# Pharmacokinetic Evaluation of a New Naloxone Nasal Swab, Naloxone Nasal Spray, and Intramuscular Naloxone Injection in Healthy Volunteers

> **NCT05363501** · PHASE1 · COMPLETED · sponsor: **Pocket Naloxone Corp** · enrollment: 76 (actual)

## Conditions studied

- Opioid Overdose

## Interventions

- **DRUG:** IM Naloxone Injection
- **DRUG:** Naloxone Nasal Spray
- **DRUG:** Naloxone Nasal Swab
- **DRUG:** Naloxone Nasal Swab
- **DRUG:** Naloxone Nasal Swab
- **DRUG:** Naloxone Nasal Swab

## Key facts

- **NCT ID:** NCT05363501
- **Lead sponsor:** Pocket Naloxone Corp
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2021-01-21
- **Primary completion:** 2022-04-03
- **Final completion:** 2022-04-11
- **Target enrollment:** 76 (ACTUAL)
- **Last updated:** 2022-05-06


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05363501

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05363501, "Pharmacokinetic Evaluation of a New Naloxone Nasal Swab, Naloxone Nasal Spray, and Intramuscular Naloxone Injection in Healthy Volunteers". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT05363501. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*